Two new oral medicines for Covid-19 are poised for widespread use, Elizabeth Tracey reports
Podcast: Download (Duration: 1:07 — 1.6MB)
Subscribe: RSS
Both Pfizer and Merck have recently revealed promising data on oral medicines for early Covid-19 infection, with both companies on the threshold of widespread use of the drugs. Brian Garibaldi, a critical care medicine expert at Johns Hopkins, says he …